top of page


Exploring the Research Behind Stacking Tirzepatide and Tesamorelin
In the world of metabolic health and body composition, interest has grown around the idea of combining Tirzepatide and Tesamorelin. While both compounds affect fat metabolism, they work through completely different biological pathways, leading researchers and clinicians to explore whether they may offer complementary benefits when used together. However, it is important to note that the combination remains largely theoretical, as no large human clinical trials have specifical
SmartPep
Oct 262 min read


Eli Lilly vs. Peptide Companies: Two Sides of the Retatrutide Lawsuit Debate
Explore Research Materials The peptide industry was shaken recently when Eli Lilly filed lawsuits against several companies accused of selling products purported to contain Retatrutide, the company's highly anticipated investigational obesity and diabetes drug. Retatrutide has generated significant attention because of promising clinical trial results, but it has not yet received FDA approval for human use. According to Lilly, the lawsuits target companies that are allegedly
SmartPep
Aug 182 min read


Tirzepatide Research: A Promising Advance in Obesity and Type 2 Diabetes
Tirzepatide is a relatively new medication that has attracted significant attention in medical research because of its ability to improve blood sugar control and promote substantial weight loss. Unlike earlier therapies that target only the GLP-1 hormone pathway, tirzepatide activates both the glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors. This dual action appears to enhance its effectiveness in treating metabolic disease. Clinical trials have shown i
SmartPep
Jul 212 min read
bottom of page